Table 28.
Occurrence of resistance (%) to selected antimicrobials in Salmonella spp., S. Kentucky and S. Derby from flocks of fattening turkeys, using ECOFFs, EU MSs, 2016
| Country | N | GEN | CHL | AMP | CTX | CAZ | MEM | TGC | NAL | CIP | AZM | COL | SMX | TMP | TET |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salmonella spp. | |||||||||||||||
| Austria | 11 | 0 | 0 | 9.1 | 0 | 0 | 0 | 0 | 36.4 | 36.4 | 0 | 0 | 27.3 | 0 | 27.3 |
| Croatia | 33 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 81.8 | 78.8 | 0 | 0 | 3 | 0 | 6.1 |
| Cyprusa | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 100 | 100 | 100 |
| Czech Republic | 11 | 9.1 | 0 | 27.3 | 0 | 0 | 0 | 0 | 9.1 | 9.1 | 0 | 9.1 | 9.1 | 0 | 27.3 |
| Finlanda | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| France | 31 | 0 | 3.2 | 32.3 | 0 | 0 | 0 | 0 | 29 | 29 | 0 | 0 | 38.7 | 19.4 | 41.9 |
| Germany | 27 | 0 | 3.7 | 77.8 | 0 | 0 | 0 | 3.7 | 14.8 | 11.1 | 0 | 0 | 74.1 | 3.7 | 74.1 |
| Hungary | 170 | 8.2 | 0.6 | 45.9 | 0 | 0 | 0 | 10 | 69.4 | 92.9 | 1.8 | 0 | 38.8 | 15.9 | 74.7 |
| Italya | 8 | 12.5 | 0 | 12.5 | 0 | 0 | 0 | 0 | 12.5 | 12.5 | 0 | 0 | 50 | 25 | 50 |
| Poland | 17 | 23.5 | 11.8 | 47.1 | 0 | 0 | 0 | 0 | 47.1 | 52.9 | 0 | 5.9 | 47.1 | 0 | 47.1 |
| Portugala | 2 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 100 |
| Romaniaa | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Sloveniaa | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Spain | 171 | 15.8 | 22.8 | 70.2 | 3.5 | 0.6 | 0 | 12.9 | 38 | 69.6 | 1.2 | 0 | 60.2 | 35.1 | 66.7 |
| United Kingdom | 170 | 0.6 | 0.6 | 5.3 | 0 | 0 | 0 | 0 | 1.8 | 1.8 | 0 | 0 | 74.1 | 2.4 | 75.3 |
| Total (15 MSs) | 663 | 7.2 | 6.8 | 38.3 | 0.9 | 0.2 | 0 | 6 | 36.5 | 50.5 | 0.8 | 0.3 | 52.3 | 15.2 | 64.1 |
| S. Kentucky | |||||||||||||||
| Czech Republica | 1 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 100 | 0 | 100 |
| Hungary | 14 | 71.4 | 0 | 92.9 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 71.4 | 0 | 78.6 |
| Italya | 1 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 100 | 0 | 100 |
| Polanda | 4 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 100 | 0 | 100 |
| Spain | 26 | 88.5 | 11.5 | 92.3 | 0 | 0 | 0 | 3.8 | 96.2 | 100 | 3.8 | 0 | 88.5 | 11.5 | 84.6 |
| Total (5 MSs) | 46 | 84.8 | 6.5 | 93.5 | 0 | 0 | 0 | 2.2 | 97.8 | 100 | 2.2 | 0 | 84.8 | 6.5 | 84.8 |
| S. Derby | |||||||||||||||
| Francea | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 100 |
| Spain | 49 | 0 | 34.7 | 93.9 | 0 | 0 | 0 | 30.6 | 2 | 67.3 | 0 | 0 | 100 | 98 | 98 |
| United Kingdom | 91 | 0 | 0 | 4.4 | 0 | 0 | 0 | 0 | 1.1 | 1.1 | 0 | 0 | 81.3 | 1.1 | 81.3 |
| Total (2 MSs) | 143 | 0 | 11.9 | 35 | 0 | 0 | 0 | 10.5 | 1.4 | 23.8 | 0 | 0 | 88.1 | 34.3 | 87.4 |
ECOFFs: epidemiological cut‐off values; EUCAST: European Committee on Antimicrobial Susceptibility Testing; N: number of isolates tested; MSs: Member States; GEN: gentamicin; CHL: chloramphenicol; AMP: ampicillin; CTX: cefotaxime; CAZ: Ceftazidime; MEM: meropenem; TGC: tigecycline; NAL: nalidixic acid; CIP: ciprofloxacin; AZM: azithromycin; COL: colistin; SMX: sulfamethoxazole; TMP: trimethoprim; TET: tetracycline.
a
The occurrence of resistance is assessed on less than 10 isolates and should only be considered as part of the total from all MSs data.